A Study to Evaluate a Range of Dose Levels of an Adenovirus Serotype 26 (Ad26.RSV.preF)-Based Vaccine in Older Adults
Clinical trial NCT04453202 · COMPLETED
Trial details
- NCT number
- NCT04453202
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-16
- Primary completion
- 2020-09-24
- Enrollment
- 459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.